AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT03548701 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Thromboelastometry testing
Description: Thromboelastometry testing - a form of testing in whole blood for coagulation abnormalities
Study NCT01624701 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Ex vivo expanded cord blood cells
Description: Cord blood cells will be expanded ex vivo using a combination of stem cell factor (SCF), thrombopoietin (TPO), Flt3 ligand and IGFBP2 with mesenchymal stromal cell (MSC) co-culture.
Study NCT02873741 — intervention group
Intervention type: PROCEDURE
Intervention: Perianal and Digital Anorectal Exam
Description: The physician will inspect the outside of the anus and use a gloved finger to feel the anus for any masses.
Study NCT02873741 — intervention group
Intervention type: PROCEDURE
Intervention: Cervical Swabs
Description: A speculum will be inserted into the vagina to visualize the cervix. The sample for research tests will be collected with one ThinPrep cytobroom inserted into the cervix. Collection will be same for the sample to be paced in the RNA storage solution for future biomarker studies.
Study NCT02873741 — intervention group
Intervention type: PROCEDURE
Intervention: Anal Swabs
Description: The anal cytology specimen will be collected by inserting a saline moistened cotton-tipped swab into the anus, rotating it clock-wise for 20 seconds, and placed in SurePath. The first twenty participants will have anal cells collected in two different ways for validation/optimization: 1) saline moistened Dacron swab placed directly in ThinPrep medium and 2) Medscand Cytobrush Plus, a special brush, placed directly into ThinPrep medium. After validation/optimization is complete for up to 20 participants, the best collection method will be selected and will be used for all future enrolled participants.
Study NCT02873741 — intervention group
Intervention type: PROCEDURE
Intervention: High Resolution Anoscopy (HRA)
Description: High Resolution Anoscopy is a procedure that allows for examination and evaluation of the anal canal. Using a small thin round tube called an anoscope, the anal canal is examined with a high resolution magnifying instrument called a colposcope. Application of a mild acidic liquid (acetic acid or diluted vinegar) or a brown iodine-based solution (Lugol's) onto the anal canal facilitates evaluation of abnormal tissue such as anal dysplasia. If abnormal staining is seen using acetic acid (dense white lesion) or Lugol's solution (bright yellow lesion) a biopsy of that area will be obtained.
Study NCT03597464 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Voclosporin
Description: Calcineurin inhibitor, oral, 23.7 mg twice daily (BID)
Study NCT03597464 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Oral Capsule
Description: Voclosporin placebo, oral, 3 capsules twice daily (BID)
Study NCT02942641 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Indwelling urethral catheterization (Foley)
Description: Hospitalized patients who developed first-time AUR were randomly divided into two groups depending on the type of assigned intervention: CIC and indwelling urethral catheter groups.~Patients in this group received indwelling urethral catheter as the intervention.
Study NCT02942641 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Clean intermittent catheterization (CIC)
Description: Hospitalized patients who developed first-time AUR were randomly divided into two groups depending on the type of assigned intervention: CIC and indwelling urethral catheter groups.~Patients in this group received CIC as the intervention.
Study NCT02942641 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Foley
Study NCT00788944 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: blood draw
Description: Test Article was not provided to subjects for this study.
Study NCT04097275 — intervention group
Intervention type: OTHER
Intervention: Skin biopsy
Description: The biopsy will be performed by means of punch biopsy (diameter 2.5 mm) under local anesthesia on a forearm. The skin biopsy will be transferred to sterile cell culture Dulbecco's Modified Eagle Medium (DMEM) 1% Penicillin 1% Streptomycin 1% Gentamycin medium 10% FBS.
Study NCT04097275 — intervention group
Intervention type: OTHER
Intervention: Withdraw of blood
Description: Blood will be collected in:~* 1 x Ethylene Diamine Tetraacetic Acid (EDTA) tube (7.5 ml) - for further leucocytes extraction that are a potential backup for new iPS cell lines generation~* 1 x Citrate Phosphate Dextrose Adenine (CPDA) tube (8.5 ml) - for EBV-transformed lymphoblastoid cell lines generation~* 1 x Dried Blood Spot DBS-filtercard, called CentoCard® - for quality control confirmatory genetic testing
Study NCT00596557 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: everolimus
Description: reduced dose CNI (cyclosporine level of 50-100)with everolimus levels of 3-8.
Study NCT01475643 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Loteprednol etabonate
Description: 1-2 Ophthalmic drops administered to study eye four times daily (QID) for 14 days post surgery. Tapered to twice daily (BID) for 7 days. Then once daily (QD) for 7 days.
Study NCT01475643 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Prednisolones acetate
Description: 1-2 Ophthalmic drops administered to study eye four times daily (QID) for 14 days post surgery. Tapered to twice daily (BID) for 7 days. Then once daily (QD) for 7 days.
Study NCT01997593 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: intraperitoneal infiltration of ropivacaine
Description: intraperitoneal infiltration of ropivacaine by a special equipment
Study NCT02243319 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HGP1201
Study NCT02243319 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HGP0904
Study NCT02243319 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HGP0904 and HGP1201 co-administraion
Study NCT00285649 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: LVVA-SM
Description: LVVA-SM, Experimental, low velocity variable amplitude spinal manipulation
Study NCT00285649 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Usual Medical Care
Description: Arm: Active Comparator: Usual Medical Care Usual Medical Care, Active Comparator, advice, exercises and medications (Celebrex, Aleve, Bextra, Naptoxen)
Study NCT04837781 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Micro-osteoperforation
Description: Micro-osteoperforation Mini-implant facilitated micro-osteoperforation (MOPs) were placed in the experimental side before canine retraction. Three MOPs were placed distal to canine on experimental sides in all group.
Study NCT03272880 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Arts-Based Programming
Description: This feasibility study includes educational components and an experiential components which are assessed with pre- and post-tests. The topics of these components include: Introduction to the Arts and Health; Music, Well-Being, and Resilience; Movement and Physical Activity; Art and Well-Being; Theater and Socialization; Art Appreciation and a Healthy Brain; and Summary/Integration of the Arts into Daily Lives. The impact of this program will be assessed with qualitative follow-up interviews.
Study NCT04363463 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: prone position
Description: Two sessions minimum of prone position over the day. With a total objective of at least 2h30 of cumulated duration over the day. The objective is to spend as much time as possible in prone position if the patient tolerates it well.
Study NCT03712995 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: 'Cutler-Beard modified with graft'
Description: A tarsoconjunctival graft was harvested from the contralateral upper eyelid, with an extra 3 mm of conjunctiva from the superior edge of tarsus and was attached to the upper eyelid defect, differently than previously described.
Study NCT02315456 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: capsulorhexis
Study NCT04120480 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Pharmacogenomic test
Description: The RightMed test is an end-to-end solution which includes sample collection, PGx testing services, data analysis, and clinical interpretation that helps prescribers select treatments based on evidence-driven predictions of patient drug response and tolerance. Genetic components of an individual's drug response are well established and often included on FDA medication labels. The RightMed test has incorporated existing evidence to classify the risk and likelihood of an antidepressant working for different patients. Patient results for each medication can fall into one of three categories: 1) Green - use as directed; 2) Yellow - use with caution; and 3) Red - adjust dose or choose alternative mediation.
Study NCT04273568 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Scapular PNF
Description: Rhythmic initiation and repetitive stretching techniques in scapula anterior elevation-posterior depression and anterior depression-posterior elevation patterns were applied twice a week for 6 weeks.
Study NCT04273568 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Exercise program
Description: An exercise program consisting of exercises used in the conservative treatment of shoulder impingement syndrome for both groups was applied twice a week for 6 weeks.
Study NCT04273568 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise program
Description: An exercise program consisting of exercises used in the conservative treatment of shoulder impingement syndrome for both groups was applied twice a week for 6 weeks.
Study NCT00438776 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: olanzapine
Description: 2.5mg to 15mg daily
Study NCT00438776 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: sugar pill
Description: matching placebo to olanzapine
Study NCT03252262 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Vitalize 360
Description: A comprehensive geriatric assessment system and wellness coaching program.
Study NCT01071291 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Niaspan
Description: Niaspan™
Study NCT01071291 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Comparator: Placebo
Description: Placebo
Study NCT02544698 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: One dose of PCV13a vaccine
Study NCT02544698 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: three doses of PCV13a vaccine
Study NCT02663245 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Intervention 1
Description: * Diabetes specific consultation~* Basic training in clinical guidelines~* Platform of communication for professionals~* Training update to review and evaluate actual cases where the coaching strategy has been applied 2-hours training programme to update and review the training of month 0.~* 7-hour training programme in group coaching for primary care professionals with a theoretical and practical approach.~* Intervention based on text messaging to patients to remind them of strategies that promote behaviour change in relation to diabetes.
Study NCT02663245 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Intervention 2
Description: * 7-hour training programme in group coaching for primary care professionals with a theoretical and practical approach.~* Training update to review and evaluate actual cases where the coaching strategy has been applied 2-hour training programme to update and review the training of month 0.~* Basic training in clinical guidelines.~* Platform of communication for professionals.~* Intervention based on text messaging to patients to remind them of strategies that promote behaviour change in relation to diabetes.
Study NCT02663947 — intervention group
Intervention type: DEVICE
Intervention: ultrasonographic measurement of optic nerve sheath diameter
Description: A thick layer of gel is applied on the upper closed eyelid. The linear 7.5-MHz ultrasound probe is then placed in the gel, without exerting pressure on the eye. Three measurements are taken for each optic nerve in the transverse plane, with the probe being horizontal. The final ONSD is the mean of these measurements.
Study NCT00381108 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Tablet
Description: Two tablets, twice daily.
Study NCT00381108 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pomegranate Tablet
Description: Two tablets, twice daily.
Study NCT01413867 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: stapled hemorrhoidopexy
Description: stapled hemorrhoidopexy will be performed using the EEA stapler Covidien
Study NCT01413867 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: stapled hemorrhoidopexy
Description: stapled hemorrhoidopexy will be performed using the PPH01/03 Ethicon EndoSurgery
Study NCT04261218 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: tomivosertib
Description: Tomivoserib is supplied as a 100 mg capsule, to be taken orally.
Study NCT04261218 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: paclitaxel
Description: Taken weekly according to the current market label in combination with experimental tomivosertib.
Study NCT05255497 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Biodex Balance Exercise System
Description: Patients in the intervention group (n=14) performed exercises using the computerized BBS. The control group (n=13) was just informed about diabetes self-management.
Study NCT01818765 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Trans-ventricular-septal placement of LV pacing lead
Study NCT01818765 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pre-procedure speckle-tracking echocardiography
Description: Assessment of site of latest mechanical activation
Study NCT01818765 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Acute response assessment
Description: Cardiac output monitoring
Study NCT00860704 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: fluidotherapy with ringer-lactate
Description: a bolus of 250ml ringer-lactate is administered, if there is fluid demand monitored by the Esophageal Doppler
Study NCT02630394 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Azithromycin
Study NCT04164849 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 5-aminolevulinic acid
Description: 5-aminolevulinic acid (30 mg/ml) will be added to mononuclear cells in a dose of 3 millimolar and incubated for 1 hour
Study NCT02063022 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Intensified chemotherapy
Description: * Induction treatment with: 4 cycle of Vincristine (10.5 mg/m2), Doxorubicin (320 mg/m2) and Ifosfamide (36 mg/m2) given every 3 weeks~* Maintenance treatment for poor responder (25 weeks): Vincristine (12mg/m2), Doxorubicin (400mg/m2), Ifosfamide (63g/m2), Cyclophosphamide (4g/m2), Etoposide (1.5g/m2) and Cells Steam Transplant after Busulfan and Melphalan treatment~* Maintenance treatment (25 week) for good responder: Vincristine (12mg/m2), Doxorubicin (400mg/m2), Ifosfamide (72g/m2), Etoposide (1.8g/m2)
Study NCT03879226 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: PBMT
Description: PBMT will be applied bilaterally using the direct contact method with light pressure on the skin at different sites, namely 9 sites on the knee extensor muscles, 6 sites on the knee flexor muscles, and 2 sites on the plantar flexor muscles. A 12-diode cluster, with 4 905-nm laser diodes (12.5W peak power for each diode), 4 875-nm LED diodes (17.5 mW mean power for each diode), and 4 640-nm LED diodes (15 mW mean power for each diode), manufactured by Multi Radiance Medical® (Solon, OH, USA), will be used to apply the PBMT. The dose used for the applications during the training and/or detraining periods will be 30 Joules (J) per site (510 J per lower limb). PBMT will be applied before and after each training session and during the detraining period, depending on the group to which the volunteers are allocated.
Study NCT04164849 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Blue light photopheresis
Description: The mononuclear cells incubated with 5-aminolevulinic acid for 1 hour will be exposed to blue light.
Study NCT04164849 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Transfusion
Description: The treated cells are transferred back to the patient as a standard blood transfusion
Study NCT04164849 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Continuous Mononuclear Cell Collection (CMNC)
Description: The mononuclear cells are collected using the Spectra Optia with the Continuous Mononuclear Cell Collection protocol. 90 ml of mononuclear cells will be collected and 100 ml of 0,9% saline will be added to dilute the cells before incubation with drug and photopheresis.
Study NCT01908049 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Probiotic.
Study NCT01908049 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Study NCT03879226 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Placebo will be applied bilaterally using the direct contact method with light pressure on the skin at different sites, namely 9 sites on the knee extensor muscles, 6 sites on the knee flexor muscles, and 2 sites on the plantar flexor muscles. The placebo PBMT will per performed using the dose of 0 J per diode. The sounds and signals emitted from the device as well as the information displayed on the screen will be identical, regardless of the type of treatment (active or placebo). Placebo will be applied before and after each training session and during the detraining period, depending on the group to which the volunteers are allocated.
Study NCT03879226 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo will be applied bilaterally using the direct contact method with light pressure on the skin at different sites, namely 9 sites on the knee extensor muscles, 6 sites on the knee flexor muscles, and 2 sites on the plantar flexor muscles. The placebo PBMT will per performed using the dose of 0 J per diode. The sounds and signals emitted from the device as well as the information displayed on the screen will be identical, regardless of the type of treatment (active or placebo). Placebo will be applied before and after each training session and during the detraining period, depending on the group to which the volunteers are allocated.
Study NCT04343391 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Brief transdiagnostic cognitive-behavioral therapy
Description: Time-limited transdiagnostic evidence-based psychological treatment
Study NCT01923493 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: tuina
Description: Patients in the tuina group will receive a tuina therapy (also known as Chinese massage). A Chinese massage lasts about 20 to 30 minutes. A series of 6 sessions with 2 treatments per week is applied.
Study NCT01923493 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: no intervention
Description: Patients in the no intervention waiting list group will not receive a study intervention. They will continue their respective pre-study therapy during the study period.
Study NCT02740764 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Optimization of drug prescribing
Description: The patients included in this group will have the intervention. The optimization of drug prescribing consists to a history of the drugs prescribing leading to pharmaceutical recommendations by the pharmacist-clinician, accepted by the specialist physicians in charge of the patient at the hospital and sent to the referring physicians of patients, who can accept or not the recommendations.
Study NCT01202474 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: INSULIN GLULISINE
Description: Pharmaceutical form: solution for injection Route of administration: subcutaneous Dose regimen: once a day
Study NCT01202474 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: INSULIN GLARGINE
Description: Pharmaceutical form:solution for injection Route of administration: subcutaneous Dose regimen: 0-15 minutes before meal or within 20 minutes from the start of meal according to prandial plasma glucose values
Study NCT04343391 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Pharmacological treatment
Description: Treatment as usual in PC
Study NCT01630577 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: volume expansion using modified gelatin
Description: Volume expansion using modified gelatin was determined according to a procedure formulated by modifying guidelines produced by Weil and Henning. The maximum volume infusion during the study test was fixed at 400 ml.
Study NCT03490760 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Durvalumab
Description: Durvalumab 1500 mg (or 20 mg/m2 if \<30 kg) IV every 4 weeks
Study NCT04226144 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Breath Stacking Group
Description: Lung recruitment technique using manual bag resuscitation with oronasal mask interface
Study NCT00609297 — intervention group
Intervention type: OTHER
Intervention: medical chart review
Description: The Research Nurse will conduct a chart review after the patient's death.
Study NCT03944460 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Contraloid
Description: Oral administration of capsules, drug substance or placebo without any excipients.
Study NCT00609297 — intervention group
Intervention type: OTHER
Intervention: questionnaire administration
Description: The questionnaires will be completed at the end of week 1, week 2 and week 4.
Study NCT00609297 — intervention group
Intervention type: OTHER
Intervention: survey administration
Description: Given to patient and caregivers throughout the study
Study NCT04226144 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Breath stacking and EMT
Description: Lung recruitment technique with one way valve with counter resistance during all expiratory phase